| scholarly article | Q13442814 |
| P50 | author | István Kovanecz | Q71914030 |
| P2093 | author name string | Rajfer J | |
| Vernet D | |||
| Ferrini M | |||
| Sanchez S | |||
| Gonzalez-Cadavid N | |||
| Rambhatla A | |||
| P2860 | cites work | Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. | Q46936674 |
| Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction | Q47173054 | ||
| Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells | Q47809364 | ||
| Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media | Q48035329 | ||
| ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. | Q53593987 | ||
| Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. | Q54784574 | ||
| Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells | Q73167363 | ||
| Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase | Q73226541 | ||
| Apoptosis in the rat penis after penile denervation | Q73512995 | ||
| Alterations of intracorporeal structures in patients with erectile dysfunction | Q73621328 | ||
| Intracellular cyclic nucleotide analogues inhibit in vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys | Q76385637 | ||
| Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function | Q77608332 | ||
| Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus | Q79870373 | ||
| Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet | Q81065390 | ||
| Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects | Q83858486 | ||
| Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival | Q28568576 | ||
| Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data | Q31030073 | ||
| Posttranscriptional regulation of human iNOS by the NO/cGMP pathway | Q31955904 | ||
| Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques | Q34466554 | ||
| Regulation of gene expression by cyclic GMP. | Q35596371 | ||
| Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy | Q35633896 | ||
| Molecular pathophysiology and gene therapy of aging-related erectile dysfunction | Q35974860 | ||
| Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase | Q36250976 | ||
| The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection | Q36353880 | ||
| Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. | Q36400028 | ||
| Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. | Q36554423 | ||
| Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. | Q38314627 | ||
| Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle | Q42469573 | ||
| Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells | Q42485586 | ||
| Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes. | Q42521654 | ||
| Antifibrotic role of inducible nitric oxide synthase | Q43920633 | ||
| Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes | Q44081098 | ||
| Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease | Q44167476 | ||
| Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model | Q44225755 | ||
| Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. | Q44362077 | ||
| Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity | Q44527078 | ||
| Erectile dysfunction after radical prostatectomy | Q44695335 | ||
| Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy | Q44721055 | ||
| YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells | Q44734191 | ||
| L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures | Q44783709 | ||
| Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. | Q44907848 | ||
| Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress | Q44978365 | ||
| Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis | Q45175833 | ||
| Corporal veno-occlusive dysfunction in aging rats: evaluation by cavernosometry and cavernosography | Q45185349 | ||
| Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk | Q45231632 | ||
| Histological alterations in cavernous tissue after radical prostatectomy. | Q45968091 | ||
| Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction | Q46373231 | ||
| Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. | Q46392230 | ||
| Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells | Q46427835 | ||
| Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation | Q46455423 | ||
| Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. | Q46600601 | ||
| In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect | Q46689741 | ||
| Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis | Q46696032 | ||
| Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin | Q46910494 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 202-212 | |
| P577 | publication date | 2007-09-20 | |
| P1433 | published in | International Journal of Impotence Research | Q15749221 |
| P1476 | title | Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats | |
| P478 | volume | 20 |
| Q35570950 | Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice |
| Q46008024 | Bulbocavernosus reflex testing: a preliminary study on the prognostic factors for potency and response to sildenafil citrate after bilateral nerve-sparing radical prostatectomy. |
| Q64095357 | Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury |
| Q92771605 | Combination of LIM-kinase 2 and Jun Amino-terminal Kinase Inhibitors Improves Erectile Function in a Rat Model of Cavernous Nerve Injury |
| Q35643372 | Current penile-rehabilitation strategies: Clinical evidence |
| Q27693838 | Current status of penile rehabilitation after radical prostatectomy |
| Q34788432 | Development of UK recommendations on treatment for post-surgical erectile dysfunction. |
| Q43772153 | Effect of chronic low-dose tadalafil on penile cavernous tissues in diabetic rats |
| Q36682260 | Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. |
| Q47394896 | Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats. |
| Q30462352 | Effects of sildenafil and/or muscle derived stem cells on myocardial infarction |
| Q91686847 | Effects of tadalafil to prevent injury on corpus cavernosum after vascular or nervous peri-prostatic bundle injury. Experimental model in rats |
| Q37573390 | Erectile dysfunction following prostatectomy: prevention and treatment |
| Q38634621 | Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis |
| Q37905577 | Erectile preservation following radical prostatectomy |
| Q48925692 | Factors predicting outcomes of penile rehabilitation with udenafil 50 mg following radical prostatectomy |
| Q37373199 | Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. |
| Q33694628 | Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling |
| Q27025843 | Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction? |
| Q38201403 | Is there a rationale for penile rehabilitation following radical prostatectomy? |
| Q45868199 | Maintenance of the contractile phenotype in corpus cavernosum smooth muscle cells by Myocardin gene therapy ameliorates erectile dysfunction in bilateral cavernous nerve injury rats. |
| Q38675045 | Models for erectile dysfunction and their importance to novel drug discovery |
| Q49720693 | Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails |
| Q43220147 | Outcome of preemptive penile rehabilitation before bilateral cavernosal nerve injury in rats |
| Q42341526 | PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? | Opinion: No. |
| Q35827798 | PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer |
| Q53757607 | Penile Rehabilitation Strategies Among Prostate Cancer Survivors. |
| Q37306884 | Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve |
| Q51134530 | Penile rehabilitation after pelvic cancer surgery. |
| Q37881305 | Penile rehabilitation after prostate cancer treatment: outcomes and practical algorithm |
| Q26773762 | Penile rehabilitation after radical prostatectomy: does it work? |
| Q38119268 | Penile rehabilitation after radical prostatectomy: what the evidence really says |
| Q37417114 | Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art. |
| Q41955108 | Penile rehabilitation should not be the norm for patients post-radical prostatectomy |
| Q37623097 | Penile shortening after radical prostatectomy and Peyronie's surgery |
| Q64234477 | Perplexity of penile rehabilitation following radical prostatectomy |
| Q39636620 | Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy. |
| Q43796722 | Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy |
| Q102141767 | Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities |
| Q26773619 | Prevention and management of post prostatectomy erectile dysfunction |
| Q36900830 | Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. |
| Q54982368 | Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury. |
| Q41600750 | Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. |
| Q43177436 | Should penile rehabilitation become the norm following radical prostatectomy? |
| Q92150232 | Sildenafil in postprostatectomy erectile dysfunction (perspective) |
| Q36542393 | Sildenafil promotes neuroprotection of the pelvic ganglia neurones after bilateral cavernosal nerve resection in the rat. |
| Q34788065 | Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat |
| Q34963295 | Sonic hedgehog protein is decreased and penile morphology is altered in prostatectomy and diabetic patients |
| Q41863269 | Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease |
| Q38781610 | The application of wrapping ureter by a pedicled gastrocolic omentum flap combined with an artificial external scaffold to prevent stoma stenosis in rabbit after ureterocutaneostomy |
| Q35185993 | The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. |
| Q37446059 | The role and structure of a postradical prostatectomy penile rehabilitation program |
| Q91785916 | The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective |
| Q38902584 | Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction |
| Q37704966 | Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy |
| Q36082711 | Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat. |
| Q45938670 | [Cavernous tissue rehabilitation whit sildenafil 100 mg in patients after radical prostatectomy]. |
| Q81109885 | [Corpus cavernosum rehabilitation after radical urooncological procedures] |
Search more.